| __timestamp | Amneal Pharmaceuticals, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 106735000 | 19586000 |
| Thursday, January 1, 2015 | 136870000 | 29135000 |
| Friday, January 1, 2016 | 204747000 | 42791000 |
| Sunday, January 1, 2017 | 191938000 | 49577000 |
| Monday, January 1, 2018 | 210451000 | 89209000 |
| Tuesday, January 1, 2019 | 202287000 | 69099000 |
| Wednesday, January 1, 2020 | 190585000 | 75961000 |
| Friday, January 1, 2021 | 209563000 | 90467000 |
| Saturday, January 1, 2022 | 200046000 | 74552000 |
| Sunday, January 1, 2023 | 167778000 | 91593000 |
In pursuit of knowledge
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Amneal Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Amneal consistently allocated a significant portion of its resources to R&D, peaking in 2018 with a 97% increase from 2014. However, a notable decline of 20% was observed by 2023. In contrast, Supernus Pharmaceuticals exhibited a steady upward trajectory, with R&D expenses growing by an impressive 368% over the same period, culminating in 2023. This divergence highlights Amneal's initial aggressive investment strategy, followed by a recent pullback, while Supernus has steadily ramped up its R&D efforts, potentially positioning itself for future breakthroughs. These trends underscore the dynamic nature of pharmaceutical innovation and the varied paths companies take to achieve success.
R&D Insights: How AbbVie Inc. and Amneal Pharmaceuticals, Inc. Allocate Funds
AstraZeneca PLC vs Amneal Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Zoetis Inc. vs Amneal Pharmaceuticals, Inc.
R&D Insights: How Incyte Corporation and Amneal Pharmaceuticals, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for BioMarin Pharmaceutical Inc. and Amneal Pharmaceuticals, Inc.
R&D Insights: How Corcept Therapeutics Incorporated and Supernus Pharmaceuticals, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Amneal Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Amneal Pharmaceuticals, Inc. vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Amneal Pharmaceuticals, Inc. and MannKind Corporation
Analyzing R&D Budgets: Apellis Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.
Analyzing R&D Budgets: Supernus Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.